news

On January 22, 2026, the Taiaipeptide Group’s 2026 Annual Partnering Program launch ceremony, themed “Healthy China, United for Progress,” was successfully held at the group’s headquarters. Representatives from the China Health Association, universities, partners, and various markets across the country gathered to witness Tai Ai peptide’s important strategic announcement for empowering distributors and jointly exploring new opportunities in the vast health industry.

△Ms. Wu Xia, Chairperson of Tai Ai Peptide Group

△Tang Yi, Founder of Hongrui Health Industry (Group) Co., Ltd.

At the launch ceremony, Ms. Wu Xia, the group’s chairwoman, provided an in-depth analysis of the group’s current development status and shared the achievements of its partners. Mr. Tang Yi, founder of Hongrui Health Industry (Group) Co., Ltd., a representative of the partners, expressed his strong recognition of Tai Ai Peptide’s development path and his firm confidence in future cooperation, based on his years of collaborative experience.

△Xing Qingli, former director of the Inspection Division of the Market Supervision Bureau of Hongqiao District, Tianjin Municipality

△Ning Wanglu, formerly Director of the Anti-Monopoly and Unfair Competition Enforcement Bureau of the State Administration for Industry and Commerce

△Wang Zhong, Vice Chairman of the China Health Care Association

△ Ms. Huang Yinhua, Senior Lawyer at Beijing Jingxun Law Firm

The conference specially invited Xing Qingli, former director of the Inspection Institute of the Hongqiao District Market Supervision Bureau of Tianjin, Mr. Ning Wanglu, a policy trend expert, and Ms. Huang Yinhua, a legal expert, to provide professional interpretations on market supervision communication, industrial policy opportunities, and full-cycle legal support services, providing solid support for partners to cope with market challenges and seize compliance benefits. Wang Zhong, a leader from the China Health Care Association, also attended and delivered a speech, fully affirming Tai’a Peptide’s innovative model and development prospects.

△Guo Chunyu, Director of the Research Institute of Tai Ai Peptide Group

△Guan Yueqiang, Professor and Doctoral Supervisor at Hebei University

During the academic empowerment session, Dr. Guo Chunyu, Director of the Tai’ai Peptide Group Research Institute, systematically introduced Tai’ai Peptide’s research and development history, cutting-edge advancements, and future plans in the field of peptide technology. Professor Guan Yueqiang, Director of the Hebei University Museum and a professor at the School of Life Sciences, delivered a special training session titled “Frontier Dynamics of Bioactive Peptide Research and Development.” Combining his profound academic expertise and extensive research experience, he summarized the research hotspots and development trends in the field of bioactive peptides both domestically and internationally.

△Liu Jianyong, Chairman of Tsinghua Yuan Sheng Industry Holding Group

Dealer representative Liu Jianyong vividly shared his experiences of growing and breaking into the market together with Tai Ai Peptide, using practical case studies, and expressed high expectations for the “Coaching Program.” At the end of the ceremony, witnessed by all the guests, the 2026 Coaching Program was officially launched in a technologically advanced manner, bringing the atmosphere to a climax.

△ Launch ceremony of the “Tai Ai Peptide Running Buddy Program”

This event is not only a platform for Taiaipeptide’s annual strategic plan announcement, but also a starting point for building consensus and creating a shared future through collaboration. Tai Ai Peptide Group will continue to use technology as its driving force, compliance as its foundation, and mutual benefit as its goal, working hand in hand with partners from all sectors to jointly promote the high-quality development of the health industry and contribute to the “Healthy China 2030″ initiative.